LAMEDITECH Co., Ltd. (KOSDAQ:462510)

LAMEDITECH Statistics

Total Valuation

LAMEDITECH has a market cap or net worth of KRW 43.66 billion. The enterprise value is 42.41 billion.

Market Cap	43.66B
Enterprise Value	42.41B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

LAMEDITECH has 8.80 million shares outstanding. The number of shares has increased by 8.60% in one year.

Current Share Class	8.80M
Shares Outstanding	8.80M
Shares Change (YoY)	+8.60%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	30.32%
Owned by Institutions (%)	n/a
Float	4.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.07
PB Ratio	5.19
P/TBV Ratio	5.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.73
EV / Sales	5.90
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.78

Financial Position

The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.87.

Current Ratio	1.65
Quick Ratio	0.95
Debt / Equity	0.87
Debt / EBITDA	n/a
Debt / FCF	-0.48
Interest Coverage	-55.16

Financial Efficiency

Return on equity (ROE) is -82.45% and return on invested capital (ROIC) is -41.34%.

Return on Equity (ROE)	-82.45%
Return on Assets (ROA)	-31.14%
Return on Invested Capital (ROIC)	-41.34%
Return on Capital Employed (ROCE)	-79.12%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.30
Inventory Turnover	1.12

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.37% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-37.37%
50-Day Moving Average	5,544.30
200-Day Moving Average	6,850.23
Relative Strength Index (RSI)	46.98
Average Volume (20 Days)	157,762

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LAMEDITECH had revenue of KRW 7.19 billion and -11.37 billion in losses. Loss per share was -1,299.00.

Revenue	7.19B
Gross Profit	3.15B
Operating Income	-11.84B
Pretax Income	-11.37B
Net Income	-11.37B
EBITDA	-11.25B
EBIT	-11.84B
Loss Per Share	-1,299.00

Balance Sheet

The company has 8.55 billion in cash and 7.30 billion in debt, with a net cash position of 1.25 billion or 141.97 per share.

Cash & Cash Equivalents	8.55B
Total Debt	7.30B
Net Cash	1.25B
Net Cash Per Share	141.97
Equity (Book Value)	8.42B
Book Value Per Share	957.43
Working Capital	6.67B

Cash Flow

In the last 12 months, operating cash flow was -13.16 billion and capital expenditures -2.11 billion, giving a free cash flow of -15.27 billion.

Operating Cash Flow	-13.16B
Capital Expenditures	-2.11B
Depreciation & Amortization	595.12M
Net Borrowing	12.23B
Free Cash Flow	-15.27B
FCF Per Share	-1,735.18

Margins

Gross margin is 43.79%, with operating and profit margins of -164.78% and -158.15%.

Gross Margin	43.79%
Operating Margin	-164.78%
Pretax Margin	-158.15%
Profit Margin	-158.15%
EBITDA Margin	-156.50%
EBIT Margin	-164.78%
FCF Margin	n/a

Dividends & Yields

LAMEDITECH does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.60%
Shareholder Yield	-8.60%
Earnings Yield	-26.03%
FCF Yield	-34.98%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LAMEDITECH has an Altman Z-Score of -1.17 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.17
Piotroski F-Score	1